VivoSeq
Other

Motor Function

0

Pipeline Programs

2

Active Trials

2

Companies Involved

Motor Function is an early-stage landscape with 0 programs across 2 companies. The most active players are Utrecht Institute for Pharmaceutical Sciences, Ferring.

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

89/100

Attrition Rate

8/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

12

clinical trials

Completed8 · 67%
Unknown status1 · 8%
Withdrawn1 · 8%
Not yet recruiting1 · 8%
Active, not recruiting1 · 8%

Trial Activity

12 trials

Cannabinoids and Cerebellar-Motor Functioning
Completed·YYale University·Phase 1·NCT01853020·57 enrolled
Elobixibat Colonic Motor Function Study
Withdrawn·Ferring logoFerring·Phase 2·NCT02392546
Serotonergic Modulation of Motor Function in Subacute and Chronic SCI
Unknown status··Phase 1·NCT01788969·42 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)